Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elaine M Sloand

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
Hematology/Oncology Clinics of North America|March 31, 2009
Hypocellular myelodysplasiaElaine M Sloand
Seminars in Hematology|January 9, 2008
Myelodysplastic syndromes: introductionElaine M Sloand
Seminars in Hematology|January 9, 2008
The role of the immune system in myelodysplasia: implications for therapyElaine M Sloand, Katayoun Rezvani
JAMA|February 24, 2011
Targeting immune dysregulation in myelodysplastic syndromesMatthew J Olnes, Elaine M Sloand
Hematology/Oncology Clinics of North America|April 3, 2010
Immunosuppression for myelodysplastic syndrome: how bench to bedside to bench research led to successElaine M Sloand, A J Barrett
Current Hematologic Malignancy Reports|April 29, 2010
Immunosuppressive therapy for myelodysplastic syndromes: refining the indicationsA John Barrett, Elaine M Sloand
American Journal of Hematology|March 22, 2007
Cytokine gene polymorphisms in acquired bone marrow failureVinod Gidvani, Shakti Ramkissoon, Elaine M Sloand, et al.
Annals of Internal Medicine|February 8, 2006
Brief communication: Successful treatment of pure red-cell aplasia with an anti-interleukin-2 receptor antibody (daclizumab)Elaine M Sloand, Phillip Scheinberg, Jaroslaw Maciejewski, et al.
Hematology. American Society of Hematology. Education Program|November 25, 2004
Marrow failureGrover C Bagby, Jeffrey M Lipton, Elaine M Sloand, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2008
Factors affecting response and survival in patients with myelodysplasia treated with immunosuppressive therapyElaine M Sloand, Colin O Wu, Peter Greenberg, et al.
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Hematology/Oncology Clinics of North America|March 31, 2009
Hypocellular myelodysplasiaElaine M Sloand
Seminars in Hematology|January 9, 2008
Myelodysplastic syndromes: introductionElaine M Sloand
Seminars in Hematology|January 9, 2008
The role of the immune system in myelodysplasia: implications for therapyElaine M Sloand, Katayoun Rezvani
JAMA|February 24, 2011
Targeting immune dysregulation in myelodysplastic syndromesMatthew J Olnes, Elaine M Sloand
Hematology/Oncology Clinics of North America|April 3, 2010
Immunosuppression for myelodysplastic syndrome: how bench to bedside to bench research led to successElaine M Sloand, A J Barrett
Current Hematologic Malignancy Reports|April 29, 2010
Immunosuppressive therapy for myelodysplastic syndromes: refining the indicationsA John Barrett, Elaine M Sloand
American Journal of Hematology|March 22, 2007
Cytokine gene polymorphisms in acquired bone marrow failureVinod Gidvani, Shakti Ramkissoon, Elaine M Sloand, et al.
Annals of Internal Medicine|February 8, 2006
Brief communication: Successful treatment of pure red-cell aplasia with an anti-interleukin-2 receptor antibody (daclizumab)Elaine M Sloand, Phillip Scheinberg, Jaroslaw Maciejewski, et al.
Hematology. American Society of Hematology. Education Program|November 25, 2004
Marrow failureGrover C Bagby, Jeffrey M Lipton, Elaine M Sloand, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2008
Factors affecting response and survival in patients with myelodysplasia treated with immunosuppressive therapyElaine M Sloand, Colin O Wu, Peter Greenberg, et al.
Pageof 4